SPC534
Serplulimab
Status:
UmsóknApplication date:
12.1.2026Application published:
11.2.2026
Medicine name:
HetroniflyMedicine for children:
No
Timeline
Today
12.1.2026Application
11.2.2026Publication
Marketing license
Foreign authorization number:
EU/1/24/1870Date:
3.2.2025
Owner
Name:
Shanghai Henlius Biotech, Inc.Address:
Room 303, 304, Block 7 No. 1999 Zhangheng Road Pilot Free Trade Zone, Shanghai CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP4339615